Allied Market Research
Upcoming Allied Market Research
Tumor-specific Antigen Market

Tumor-specific Antigen Market by Product Type (CT9/CT10, Idiotypic, Lineage-Restricted Antigen, Mutated, Oncofetal, Oncoviral, Overexpressed/Accumulated and Others), Source (Coding Region, Non-Coding Region), Application (Prognostic, Therapeutic, Risk Assessment, Drug Discovery and Development, Diagnostic, Clinical, and Basic Research), and End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Dec 2021 | 90 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Tumor-specific Antigen Market

Request Now !

Antigens produced by tumor cells are known as tumor-specific antigens. They are actually cytosolic protein derivatives. Tumor antigens are promising cancer therapy possibilities because they are useful tumor markers for detecting tumor cells in diagnostic testing.

Cancer antigens are chemicals that are displayed on the surface of tumor cells by major histocompatibility complex (MHC) class I or II molecules. It activates an immune response in which Cytolytic T Lymphocytes (CTL) detect these antigens and kill tumor cells before they can proliferate.

Market Scope and Structure Analysis

Report Metric


Market Size Available for Years


Base Year Considered


Forecast Period


Forecast Unit

Value (USD)

Segments Covered

Product Type, Application, End User, and Region

Regions Covered

North America, Europe, Asia-Pacific, LAMEA

Companies Covered

Abcam Plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Biomrieux Sa, Caris Life Sciences Inc., Creative Diagnostics, Eli Lilly and Co., Enzo Biochem Inc., Hoffmann-La Roche Ltd., Janssen Global Services Llc., Go Therapeutics, Lee Biosolutions Inc., Merck Millipore, Perkinelmer Inc., Quest Diagnostics, Signosis Inc.

COVID-19 Impact analysis

The global epidemic of COVID-19 has resulted in an ongoing healthcare market decline. Leading stakeholders are continuing to adjust their strategies in response to the quickly changing environment. COVID-19 is expected to have long-term consequences for the healthcare industry. Countries and key players would have to make significant modifications to their healthcare systems until the crisis subsides. The tumor specific antigen market had a decline in demand as a result of COVID-19, and the market stopped growing as a result.

COVID-19 has the potential to impact the human identification market in three ways: directly altering production, demand, supply chain disruption, and financial impact on firms and financial markets.

Top Impacting Factors

  • Rise in incidence of cancer all over the globe, surge in demand for potential cancer biomarker candidates, and increase in investments in cancer diagnosis and research drive the growth of the global tumor-specific antigen market.
  • In addition, rise in focus on the development of targeted therapies and developments in antigen-specific T-cell therapy for cancer also propels the growth of the global market.
  • Moreover, the advent of advanced technologies in cancer immunotherapy and regulatory approval of new monoclonal antibodies is likely to gain significant impetus for the tumor-specific antigen market share in the forthcoming years.
  • Increased R&D expenditure in the pharmaceutical and biopharmaceutical industry is expected to drive the demand for oncology small molecule drugs.
  • Rise in income as well as surge in government support to the healthcare systems in developing nations is expected to aid in sustaining the growth of the tumor-specific antigen market.
  • However, the high cost of drug discovery and development and stringent regulations for oncology small molecule drugs is likely to restrict the growth of the market.

Market Trends

New product launches to flourish the market

In April 2021, Roche announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test is used to aid physicians to diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests. The assay is now available for all markets accepting the CE Mark.

In June 2020, FDA approved Merck’s KEYTRUDA® (pembrolizumab) for first-line treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer.

Key Segments Covered



Product Type

  • CT9/CT10
  • Idiotypic
  • Lineage-Restricted Antigen
  • Mutated
  • Oncofetal
  • Oncoviral
  • Overexpressed/Accumulated
  • Others


  • Coding Region
  • Non-Coding Region


  • Prognostic
  • Therapeutic
  • Risk Assessment
  • Drug Discovery and Development
  • Diagnostic
  • Clinical and Basic Research

End User

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Benefits of the Report

  • This study presents the analytical depiction of the Tumor-specific Antigen along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Tumor-specific Antigen market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the Tumor-specific Antigen market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Tumor-specific Antigen market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Tumor-specific Antigen Report

  • Who are the leading market players active in the Tumor-specific Antigen market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "Tumor-specific Antigen"?
  • What is "Tumor-specific Antigen" Market prediction in the future?
  • Who are the leading global players in the "Tumor-specific Antigen" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Tumor-specific Antigen" Market report?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Tumor-specific Antigen Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers